Pneumococcal Vaccine

Pneumococcal Vaccine is a mixture of purified capsular polysaccharides from the 23 types of S. pneumoniae that are resposible for 90% of all pneumococcal infections. Pneumococcal Vaccine is used to provide selective immunity against infection caused by pneumococci in person over 2 years of age.


Adult Dose
Dose: 25 ug
Single Dose: 25 (25)
Frequency: As recommended.
Route: IM
Instructions: (or 0.5 ml) . Same dose for children over 2 years of age
Neonatal
Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group
Paedriatic
Dose: 25 ug
Single Dose: 25 (25)
Frequency: As recommended.
Route: Intra Muscular
Instructions: As Required
Characteristics
. It is of Natural origin and belongs to Polysaccharides. It belongs to Toxoids and Vaccines pharmacological group.
Contraindications
Pneumococcal Vaccine is contraindicated in conditions like Pregnancy,Hypersensitivity to any component of product.
Effects
The symptomatic adverse reactions produced by Pneumococcal Vaccine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Fever, Rashes, Allergic reactions, Soreness, Redness at injection site.
Indications
Pneumococcal Vaccine is primarily indicated in conditions like CSF leak, Pneumonia, and can also be given in adjunctive therapy as an alternative drug of choice in AIDS.
Interactions
No data regarding the interactions of Pneumococcal Vaccine was found.
Interfrence
None well documented
Risks
Drug should not be given to Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
SC Inj, IM Inj Store in refrigerator. Do not Freeze. Protect from Sunlight.
Warnings
Vaccination should be postponed in patients suffering from any acute illness. Immunization should not be carried out in individuals who have previously had a severe local or general reaction to the vaccine. Some vaccine contains antibiotics in small amount and should not be given to patients with history of anaphylaxis to the agent used. It should be given atleast 10 days before starting immunosuppressive therapy or be delayed until atleast 6 months after completion of therapy. It is not recommended to use in children under 2yr of age.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.